Category Archives: Platelet Rich Plasma Injections


AIM ImmunoTech Expands Patent Portfolio with New Netherlands Composition and Methods Patent Covering Ampligen for Use in the Post-COVID Condition of…

OCALA, Fla., Dec. 12, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that the Netherlands Patent Office (Octrooicentrum Nederland) has granted Patent No. 2,032,813 — a compositions and methods patent — covering Ampligen® (rintatolimod) for use in the treatment of the post-COVID condition of fatigue. The patent inventors, AIM CEO Thomas K. Equels and AIM Medical Officer David R. Strayer, M.D., have assigned the granted patent to the Company.

Visit link:
AIM ImmunoTech Expands Patent Portfolio with New Netherlands Composition and Methods Patent Covering Ampligen for Use in the Post-COVID Condition of...

XORTX Announces Presentation at the Rare and Genetic Disease Summit

CALGARY, Alberta, Dec. 12, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, is pleased to announce a presentation by Dr. Allen Davidoff at the Rare and Genetic Kidney Disease Summit, in Boston, Massachusetts at 10:30 am ET, Thursday December 12, 2024. The presentation entitled “Autosomal Dominant Polycystic Kidney Disease - Genetic and Environmental Factors ? Evidence for Aberrant Purine Metabolism as a Second Hit Determining Disease Progression.”

View original post here:
XORTX Announces Presentation at the Rare and Genetic Disease Summit

Cannara Biotech to Host Investor Webcast on Thursday December 19th, 2024

MONTREAL, Dec. 12, 2024 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (“Cannara”, “the Company”, “us” or “we”) (TSXV: LOVE) (OTCQB: LOVFF) (FRA: 8CB0), a vertically integrated producer of premium-grade cannabis and derivative product offerings at affordable prices with two mega facilities based in Quebec spanning over 1,650,000 sq. ft., today announced that it will host a webcast investor presentation on Thursday, December 19th, 2024, at 2:00 PM ET.

Continued here:
Cannara Biotech to Host Investor Webcast on Thursday December 19th, 2024

Invea Therapeutics Strengthens Leadership with Appointment of Dr. Stephen Doberstein, Veteran Biotech Executive, to Its Board of Directors

Dr. Doberstein brings extensive biotech leadership experience as the company advances its AI-powered pipeline into Phase 2 for immune-mediated inflammatory disorders Dr. Doberstein brings extensive biotech leadership experience as the company advances its AI-powered pipeline into Phase 2 for immune-mediated inflammatory disorders

Read more here:
Invea Therapeutics Strengthens Leadership with Appointment of Dr. Stephen Doberstein, Veteran Biotech Executive, to Its Board of Directors

Aptose Announces Publication of Preclinical Data in AACR Journal Demonstrating Tuspetinib’s Unique Mechanism of Action and Synthetic Lethality on…

SAN DIEGO and TORONTO, Dec. 12, 2024 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (NASDAQ: APTO, TSX: APS), a clinical-stage precision oncology company developing highly differentiated targeted agents to treat hematologic malignancies, today announced the publication of preclinical data for Aptose’s lead hematology compound tuspetinib (TUS) in Cancer Research Communications, a journal of the American Association for Cancer Research (AACR), available online now (link).

View post:
Aptose Announces Publication of Preclinical Data in AACR Journal Demonstrating Tuspetinib’s Unique Mechanism of Action and Synthetic Lethality on...

Palisade Bio Announces Pricing of $5 Million Underwritten Public Offering Priced At-Market Under Nasdaq Rules

Carlsbad, CA, Dec. 12, 2024 (GLOBE NEWSWIRE) -- Palisade Bio, Inc, (Nasdaq: PALI) (“Palisade,” “Palisade Bio” or the “Company”), a clinical-stage biopharmaceutical company focused on developing novel therapeutics for autoimmune, inflammatory, and fibrotic diseases, today announced the pricing of an underwritten public offering for gross proceeds of approximately $5 million prior to deducting underwriting commissions and offering expenses. The offering is comprised of (i) 158,000 Class A Units with each unit consisting of (a) one share of common stock and (b) one common warrant to purchase one share of common stock (the “Common Warrants”), and (ii) 3,120,688 Class B Units with each unit consisting of (a) one prefunded common stock purchase warrant to purchase one share of common stock (“Prefunded Warrants”) and (b) one Common Warrant. The price per Class A Unit is $1.525 and the price per Class B Unit is $1.5249 (collectively, the “Offering”).

Continue reading here:
Palisade Bio Announces Pricing of $5 Million Underwritten Public Offering Priced At-Market Under Nasdaq Rules

PRP Under Eye Treatment: What You Should Know – The Herald-News

Tired of looking in the mirror and seeing those unwanted signs of aging around your eyes? Forget going under the knife theres a new option that harnesses the power of your own body to achieve a brighter, more youthful appearance.

Platelet-Rich Plasma (PRP) injections are a revolutionary treatment offered at Eterna MedSpa & Laser Vein Center that can tackle a multitude of under-eye concerns.

The procedure uses a clients own blood plasma to tighten the skin and reduce wrinkles. How?

During the treatment, a small amount of blood is drawn and then placed in a centrifuge where it is spun at high speeds so the plasma rises to the top. The plasma is then drawn out into a syringe and injected in the under eye area.

The plasma contains proteins which strengthen and volumize the skin. In the under-eye area, rejuvenation occurs, stimulating the natural production of collagen, elastin, and hyaluronic acid.

The benefits of Platelet-Rich Plasma extend beyond just wrinkle reduction.

PRP helps with dark circles, puffiness, and shallowness under the eyes, said Kathe Malinowski, lead esthetician and Marketing Manager for Eterna MedSpa & Laser Vein Center. It also minimizes crepey skin under the eye area.

The results of the injections can last anywhere from six months to a year, depending on your individual age and skin condition.

Wondering if Platelet-Rich Plasma therapy is the right choice for you? Eterna MedSpa offers complimentary consultations with a nurse where you can discuss your goals and get a personalized treatment plan.

Dont wait any longer to achieve the beautiful, youthful eyes you deserve explore the power of PRP at Eterna MedSpa & Laser Vein Center.

For more information, please contact:

Eterna MedSpa & Laser Vein Center : 217 Vertin Boulevard : Shorewood, IL 60404 : 815.254.8888 : https://www.eternalaser.com/

[SPONSORED] Eterna MedSpa offers products that rejuvenate Jessica Knowles of Eterna MedSpa discusses the importance of skincare products. Injectables and other procedures provided by Eterna MedSpa will only take patients so far. Regular skin care is necessary to keep your skin looking smooth and youthful.

Original post:
PRP Under Eye Treatment: What You Should Know - The Herald-News

Stem Cell and Platelet Rich Plasma Alopecia Therapies Market Analysis and Future Outlook by 2030 – openPR

The global stem cell and platelet rich plasma alopecia therapies market is expected to grow at a significant CAGR during the forecast period. Increased need for accurate and rapid alopecia treatment, as well as breakthroughs in platelet rich plasma and stem cell therapies that have transformed diagnostic technology, which is expected to drive the market forward. Furthermore, the global market is likely to be driven by an increase in awareness of platelet rich plasma therapies and stem cell therapies over the forecast period.

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/stem-cell-and-platelet-rich-plasma-alopecia-therapies-market

In the last few years, increased awareness has fueled demand for platelet rich plasma therapy and stem cell therapy in developing countries like Japan, India, Brazil, and Russia, as well as developed regions like North America and Europe. Furthermore, private actors are actively marketing the benefits of stem cell therapy in the treatment of alopecia around the globe. The global stem cell and platelet rich plasma alopecia therapies market is expected to grow as the incidence of autoimmune hair loss disorders such as alopecia rises. However, the global market for stem cell and platelet rich plasma alopecia therapies is anticipated to be hampered by a lack of therapy approval and the high cost of alopecia treatment.

The global market has been divided into platelet rich plasma therapies and stem cell therapy based on treatment. Owing to the therapies' efficiency in the treatment of several forms of alopecia, the platelet rich plasma therapies sector had a substantial market share. Platelet-rich plasma therapies have changed alopecia treatment by lowering expenses, lengthening treatment times, and speeding up recovery time for patients. The bone marrow and adipose stem cell treatment segments have been separated.

Global Stem Cell and Platelet Rich Plasma Alopecia Therapies Market by Segments

By Treatment

Platelet Rich Plasma Therapies Stem Cell Therapy

By End-User

Hospitals Dermatology Clinics Others

A full report of Stem Cell and Platelet Rich Plasma Alopecia Therapies Market is available at: https://www.omrglobal.com/industry-reports/stem-cell-and-platelet-rich-plasma-alopecia-therapies-market

Stem Cell and Platelet Rich Plasma Alopecia Therapies Market- Segment by Region

North America

United States Canada

Europe

Germany United Kingdom France Spain Italy Rest of Europe

Asia-Pacific

China Japan India Rest of Asia-Pacific

Rest of the World

Middle East & Africa Latin America

Company Profiles

Stemcell technologies Inc. Myungmoon Bio Co., Ltd. RepliCel Life Sciences Histogen, Inc. Glofinn Oy.

Reasons to Buying From us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors. 2. More than 120 countries are for analysis. 3. Over 100+ paid data sources mined for investigation. 4. Our expert research analysts answer all your questions before and after purchasing your report.

Visit more report at

https://www.linkedin.com/pulse/scaffold-technology-market-size-trends-latest-arti-vishwakarma-mlsof/

https://www.linkedin.com/pulse/aesthetic-threads-market-increasing-demand-growth-2031-vishwakarma-pyg5f

Media Contact:

Contact Person: Mr. Anurag Tiwari Email: anurag@omrglobal.com Contact no: +91 780-304-0404 Company Name: Orion Market Research

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.

This release was published on openPR.

Go here to read the rest:
Stem Cell and Platelet Rich Plasma Alopecia Therapies Market Analysis and Future Outlook by 2030 - openPR

Vampire Breast Lift 101: Everything to Know About the Trending Treatment – NewBeauty Magazine

By now you must have heard of the Vampire Facial which was first popularized in 2013 when Kim Kardashian took a now infamous bloody selfie. Just like the Vampire Facial, the Vampire Breast Lift utilizes platelet-rich plasma (PRP) derived from a persons own blood. The Vampire Breast Lift involves injections of PRP in the breasts to enhance fullness and lift for a quick cleavage boost.

Developed by Fairhope, AL, dermatologist Charles Runels, MD, the procedure involves drawing blood, isolating platelets containing growth factors, and combining them with hyaluronic acid fillers. Injecting this cocktail directly into the breasts can address concerns like inverted nipples, sagging, stretch marks and lack of perkiness.

Huntington Beach, CA, plastic surgeonPeter Newen, MD says that PRP injections may improve skin quality, but dont expect a lift. PRP injections may achieve some skin improvement but claims such as increased fatty tissue volume and lifting will not be observable, says Dr. Newen.

Although patients may see a temporary improvement, the results do not compare to a traditional breast lift. This should not be compared with a surgical breast lift or augmentation, in which there is a clear, long-lasting improvement.Adding PRP to the breasts can improve theskin, but it wont make a noticeable difference in breast volume or perkiness, he adds.

Dr. Runels claims that the effects of the Vampire Breast Lift may last one to two years, although these assertions lack independent verification. Grand Rapids, MI, plastic surgeonBradley Bengtson, MDexpresses concerns about the lack of data and clinical studies supporting the procedures safety and efficacy. Candidates for the Vampire Breast Lift should consult with a qualified medical professional to assess suitability and potential risks. The concerns I have with this procedureare that it tends to be performed by non-core physicians and nonsurgical doctors. There is absolutely no data about it yet, nor have there been any studies or findings on either the benefits or clinical risks associated with it, says Dr. Bengtson.

The procedure, which reportedly takes just 15 minutes, typically ranges in cost from $1,500 to $2,000. However, the exact price may vary depending on factors such as practice location and the expertise of the administering physician.

There are minimal risks, including potential bruising and swelling that typically resolve within a few days. It is essential for individuals considering this treatment to consult with board-certified providers.

While the procedure is generally deemed safe, Dr. Bengtson highlights the lack of conclusive evidence regarding long-term safety, particularly in relation to its potential impact on breast health. The breast is a cancer-prone organ, and with one in eight women in the U.S. developing breast cancer, you must wonder, what effect do these injections have on an established cancer? We dont have an answer to that yet, he cautions.

As of now, there is no FDA approval specifically for this procedure. Patients considering this treatment should thoroughly discuss potential side effects and concerns with their healthcare provider before proceeding.

Read more from the original source:
Vampire Breast Lift 101: Everything to Know About the Trending Treatment - NewBeauty Magazine